Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 10
1973 3
1976 1
1978 1
1979 1
1984 1
1987 2
1990 3
1991 6
1992 10
1993 10
1994 11
1995 12
1996 5
1997 12
1998 7
1999 5
2000 15
2001 14
2002 20
2003 17
2004 23
2005 23
2006 12
2007 15
2008 12
2009 11
2010 17
2011 10
2012 12
2013 14
2014 13
2015 21
2016 13
2017 12
2018 16
2019 23
2020 19
2021 14
2022 8
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
Migraine.
Silberstein SD. Silberstein SD. Lancet. 2004 Jan 31;363(9406):381-91. doi: 10.1016/S0140-6736(04)15440-8. Lancet. 2004. PMID: 15070571 Review.
Preventive Migraine Treatment.
Silberstein SD. Silberstein SD. Continuum (Minneap Minn). 2015 Aug;21(4 Headache):973-89. doi: 10.1212/CON.0000000000000199. Continuum (Minneap Minn). 2015. PMID: 26252585 Free PMC article. Review.
Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Silberstein SD, et al. Neurology. 2012 Apr 24;78(17):1337-45. doi: 10.1212/WNL.0b013e3182535d20. Neurology. 2012. PMID: 22529202 Free PMC article. Review.
Neuropeptides.
Silberstein SD. Silberstein SD. Headache. 2017 May;57 Suppl 2:35-36. doi: 10.1111/head.13093. Headache. 2017. PMID: 28485847 No abstract available.
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group. Dodick DW, et al. Among authors: silberstein sd. Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7. Headache. 2010. PMID: 20487038 Clinical Trial.
Fremanezumab for the Preventive Treatment of Chronic Migraine.
Silberstein SD, Dodick DW, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E. Silberstein SD, et al. N Engl J Med. 2017 Nov 30;377(22):2113-2122. doi: 10.1056/NEJMoa1709038. N Engl J Med. 2017. PMID: 29171818 Free article. Clinical Trial.
429 results